| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| General and administrative costs | 155,513 | |||
| Loss from operations | -155,513 | |||
| Interest earned on cash and investments held in trust account | 109,355 | |||
| Total other income | 109,355 | |||
| Net loss | -46,158 | |||
| Basic net loss per ordinary share (in dollars per share) | 0 | |||
| Diluted net loss per ordinary share (in dollars per share) | 0 | |||
| Weighted average ordinary shares outstanding basic (in shares) | 2,717,391 | |||
| Weighted average ordinary shares outstanding diluted (in shares) | 2,717,391 | |||
Drugs Made In America Acquisition II Corp. (DMII)
Drugs Made In America Acquisition II Corp. (DMII)